Please login to the form below

Not currently logged in
Email:
Password:

IFPMA appoints Fumie Griego as assistant director general

She joins the global pharma association from Merck KGaA

Fumie GriegoGlobal pharma association the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) has appointed Femie Griego to be its new assistant director general.

She joins from Merck KGaA, where she held senior roles such as head of global oncology policy and strategy, global government affairs policy and has also served as vice president for international health policy at Pharmaceutical Research and Manufacturers of America (PhRMA).

Prior to that Griego spent time at the White House as its senior economist where she provided US officials in both the Bush and Obama administrations with advice on a range of health and policy issues.

Thomas Cueni, director-general at IFPMA, said: “I am delighted to count on the support of Fumie Griego, a highly competent professional, whom I have chosen for her strong pharma expertise and background in global affairs, including intellectual property protection, pricing, costs, value issues and health diplomacy.

“She will be a strong asset to help IFPMA bring thought leadership in addressing global health challenges.”

Griego will join IFPMA's leadership team and will also be working on strengthening the association's work on the industry’s value proposition.

11th May 2017

From: Regulatory

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
dna Communications

Healthcare communications with unique thinking, insight and attitude...

Latest intelligence

BRIC markets
BRIC markets
Why these countries offer an opportunity for pharma despite a slowdown...
Obstetrics Virtual Journal Club: An Impetus Digital Customer Success Story
Our online solutions are not just for advisory boards - find out how one client leveraged the Impetus InSite Platform® for a virtual journal club....
Ludovic Helfgott
Novo Nordisk awakens its ‘Sleeping Beauty’
Biopharm emerges from troubled times to hit ‘solid growth’, says executive vice president Ludovic Helfgott...

Infographics